About ADVI
ADVI is a Healthcare company based in Washington (United States) founded in 2013, and was acquired by Sheridan in December 2022. Market access, consulting, and commercialization services for pharmaceuticals are provided. ADVI has completed 1 acquisition, including PHAR. ADVI offers products and services including Market Access Services, Policy Analysis Services, and Strategic Analytics Services. Its focus areas include Biopharma Outsourcing, Consulting, Business and Market Access & HEOR. Its competitors include Target RWE, Secura Bio and STATinMED Research; 1 of its 3 listed competitors has raised funding.
Company details
ADVI was founded in 2013 to deliver market access, business consulting, and commercialization services within the pharmaceutical sector. Support is extended to clients through strategic advisory on market entry, operational efficiencies, and product launches. Focus is placed on helping pharmaceutical entities address regulatory challenges, pricing strategies, and distribution networks. Services are structured to align with industry needs for sustainable growth and compliance.
- Investors
- Investments & Acquisitions
- Acquired bySheridan
(Dec 2022)
Products & Services of ADVI
ADVI offers a comprehensive portfolio of products and services, including Market Access Services, Policy Analysis Services, and Strategic Analytics Services.
Strategies to enhance market access for healthcare products
Analysis of trends and legislation for informed decisions
Data-driven economics and value assessment for products
Investors in ADVI
ADVI has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Sheridan Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sheridan Capital Partners is focused on healthcare private equity investments. | sheridancp.com | Chicago, United States |
Investor details for ADVI
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of ADVI
26 people are tracked at ADVI (14 in leadership, 12 in team).
| Name | Role | Group |
|---|---|---|
Caitlin Sheetz | Vice President And Head Of Analytics | Leadership |
Alicia Silver | Senior Director, Federal And State Policy | Leadership |
Christopher Wittwer | Chief Financial Officer | Leadership |
Victoria Chester Rose | Vice President Of People & Talent | Leadership |
Will Burchenal | Director, Business Development | Leadership |
Lori Smith-Sakalousky | President | Leadership |
Alan Sokolow | Senior Vice President | Leadership |
Marci Mutti | Executive Vice President | Leadership |
Allison Schneider | Director | Leadership |
Marc Samuels | Founder And CEO | Leadership |
Michael Beebe | Partner, Senior Vice President | Leadership |
Angela Lively | Sr Vice President | Leadership |
Lindsay Bealor Greenleaf | Vice President & Head, Federal & State Policy | Leadership |
Bruce Yeager | Vice President | Leadership |
Charles Sewell | Senior Associate | Team |
Zihao Liu | Healthcare Data Analyst | Team |
Elizabeth Barkley | Senior Account Manager, Business Development | Team |
Tracy Acheampong | Manager | Team |
Gabriela Cazares | Senior Manager Of Finance And Accounting | Team |
Antonio Garcia | Senior Business Development Associate | Team |
6 more people are available in the full profile.
Complete people profiles for ADVI
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ADVI
ADVI has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include PHAR.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
PHAR LLC provides consulting and research services to professionals | pharllc.com | Beverly Hills, United States | 2004 | Aug 2024 | •••• |
Complete acquisition details for ADVI
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Competitors of ADVI
ADVI has 3 listed competitors in our database, 1 of them funded. They include Target RWE, Secura Bio and STATinMED Research.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| targetrwe.com | 2017 | Durham, United States | 116 | Marketing services to the pharmaceutical industry are provided. | ||
| securabio.com | 2018 | Henderson, United States | $55M | Consulting services for market access and health outcomes are provided. | ||
| statinmed.com | 2007 | Ann Arbor, United States | Healthcare data analytics services provider |
Detailed competitors of ADVI
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of ADVI
The website of ADVI (advi.com) receives about 6.3K visits a month.
- Monthly visits6.3K
▲ 14.4% vs previous month
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as ADVI (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about ADVI
ADVI was founded in 2013.
ADVI is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
ADVI was founded in 2013 to deliver market access, business consulting, and commercialization services within the pharmaceutical sector. Support is extended to clients through strategic advisory on market entry, operational efficiencies, and product launches. Focus is placed on helping pharmaceutical entities address regulatory challenges, pricing strategies, and distribution networks. Services are structured to align with industry needs for sustainable growth and compliance.
ADVI's top competitors include Target RWE, STATinMED Research and Secura Bio.
ADVI offers Market Access Services, Policy Analysis Services, and Strategic Analytics Services.
ADVI has made 1 acquisition, including PHAR.
ADVI has 1 investor. Key investors include Sheridan Capital Partners.
Yes. ADVI was acquired by Sheridan in December 2022.